{"id":11485,"date":"2022-07-01T20:39:33","date_gmt":"2022-07-02T00:39:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/seventh-annual-immuno-oncology-360\/"},"modified":"2022-07-14T15:09:30","modified_gmt":"2022-07-14T19:09:30","slug":"seventh-annual-immuno-oncology-360","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/seventh-annual-immuno-oncology-360","title":{"rendered":"Seventh Annual Immuno-Oncology 360\u00b0"},"content":{"rendered":"<p><strong>Samik Upadhaya, PhD, research analyst, is speaking on the &ldquo;Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies&rdquo; virtual panel session on February 25 at 2:45 PM ET.<\/strong><\/p>\n<p>IO360\u02daconvenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.<\/p>\n<p>The 7th Annual Immuno-Oncology 360&deg; Delivers Three Key Benefits:<\/p>\n<p>Access to KOLs driving the science<br \/>\nPartnership opportunities with all stakeholders in Immuno-Oncology<br \/>\nPresentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology<\/p>\n<p>2021 Key Topic Areas<\/p>\n<ul>\n<li>Discovery\/Preclinical Science<\/li>\n<li>Cell &amp; Gene Therapy<\/li>\n<li>Translational Science<\/li>\n<li>Bispecifics<\/li>\n<li>Clinical Developments<\/li>\n<li>Neoadjuvant\/Adjuvant Data<\/li>\n<li>Emerging Biomarkers<\/li>\n<li>Vaccines<\/li>\n<li>Clinical Operations<\/li>\n<li>AI &amp; Machine Learning<\/li>\n<li>Imaging Advancements<\/li>\n<li>Business Developments<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CRI&#39;s Samik Upadhaya, PhD, speaks on the &quot;Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies&quot; panel on February 25.<\/p>\n","protected":false},"featured_media":4108,"template":"","events_categories":[203],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11485","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-cri-speaks"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Seventh Annual Immuno-Oncology 360\u00b0<\/title>\n<meta name=\"description\" content=\"CRI&#039;s Samik Upadhaya, PhD, speaks on the &quot;Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies&quot; panel on February 25.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Seventh Annual Immuno-Oncology 360\u00b0\" \/>\n<meta property=\"og:description\" content=\"CRI&#039;s Samik Upadhaya, PhD, speaks on the &quot;Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies&quot; panel on February 25.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T19:09:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e60cce6-b3de-469b-bb15-715bfbc4e8a3.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Seventh Annual Immuno-Oncology 360\u00b0\" \/>\n<meta name=\"twitter:description\" content=\"CRI&#039;s Samik Upadhaya, PhD, speaks on the &quot;Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies&quot; panel on February 25.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e60cce6-b3de-469b-bb15-715bfbc4e8a3.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360\",\"name\":\"Seventh Annual Immuno-Oncology 360\u00b0\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b53f31eb-469c-4e30-a3a8-78f9727a0571.jpg\",\"datePublished\":\"2022-07-02T00:39:33+00:00\",\"dateModified\":\"2022-07-14T19:09:30+00:00\",\"description\":\"CRI's Samik Upadhaya, PhD, speaks on the \\\"Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies\\\" panel on February 25.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b53f31eb-469c-4e30-a3a8-78f9727a0571.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b53f31eb-469c-4e30-a3a8-78f9727a0571.jpg\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Seventh Annual Immuno-Oncology 360\u00b0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Seventh Annual Immuno-Oncology 360\u00b0","description":"CRI's Samik Upadhaya, PhD, speaks on the \"Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies\" panel on February 25.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360","og_locale":"es_ES","og_type":"article","og_title":"Seventh Annual Immuno-Oncology 360\u00b0","og_description":"CRI's Samik Upadhaya, PhD, speaks on the \"Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies\" panel on February 25.","og_url":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T19:09:30+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e60cce6-b3de-469b-bb15-715bfbc4e8a3.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Seventh Annual Immuno-Oncology 360\u00b0","twitter_description":"CRI's Samik Upadhaya, PhD, speaks on the \"Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies\" panel on February 25.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e60cce6-b3de-469b-bb15-715bfbc4e8a3.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360","url":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360","name":"Seventh Annual Immuno-Oncology 360\u00b0","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b53f31eb-469c-4e30-a3a8-78f9727a0571.jpg","datePublished":"2022-07-02T00:39:33+00:00","dateModified":"2022-07-14T19:09:30+00:00","description":"CRI's Samik Upadhaya, PhD, speaks on the \"Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies\" panel on February 25.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b53f31eb-469c-4e30-a3a8-78f9727a0571.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/b53f31eb-469c-4e30-a3a8-78f9727a0571.jpg","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/seventh-annual-immuno-oncology-360#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Seventh Annual Immuno-Oncology 360\u00b0"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/4108"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11485"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11485"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11485"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11485"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11485"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11485"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}